Company
Ilios Therapeutics
Pioneering multi-functional small molecules to combat neurodegenerative diseases
- Status
- Operatingas of 2026-09-20Source (opens in a new tab)
- Business model
- B2B
- Headquarters
- Boston, MA, United States
Record updated 28 September 2026
About
Innovative chemistry platform to generate first-in-class small molecules modulating three known processes involved in neurodegeneration: protein misfolding, oxidative stress and neuro-inflammation